CAI Yong,LI Dong-ming,SUN Yan.Clinic study of CMNa radiosensitivity enhacement on malignant tumors[J].Chinese Journal of Radiological Medicine and Protection,2008,28(3):260-261
Clinic study of CMNa radiosensitivity enhacement on malignant tumors
Received:October 29, 2007  
DOI:
KeyWords:CMNa  Radiotherapy  Malignant tumors
FundProject:
Author NameAffiliation
CAI Yong Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
LI Dong-ming Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
SUN Yan Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
苏星 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
刘长青 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
肖绍文 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
铁剑 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
徐博 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
张珊文 Department of Radiation Oncology, Peking University the School of Oncology, Beijing 100036, China 
Hits: 2489
Download times: 1753
Abstract::
      Objective To evaluate the effects and safety of CMNa on radiosensitivity enhacement for malignant tumors. Methods According to the standard protocol of CMNa Ⅳ stage clinic trial, 80 patients with malignant tumors were treated with 3DCRT or conventional radiotherapy, 2 Gy/fraction and five fractions weekly. Concomitance CMNa were applied in intravenous 800 mg/m2, three times weekly. The treatment effects and side-effects were observed. Results The curative effect rates were 91.7% for cervical cancer, 85.7% for nasopharynx cancer, 66.7% for esophageal cancer, 54.5% for lung cancer, 40% for liver and gall cancer. The total curative effect rate was 62.6% and the tumor control rate was 100%. The side-effects occurrence rates of mucosa and skin which were grades 1 to 2, were 51.3% and 46.3%,respectively,which were the highest in all side-effects. There were no statistical significances between before and after treatment on the side-effects and blood test. Conclusions CMNa combined with radiotherapy can enhance the control rates of tumors with low toxicity and high safety.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9075403  On-line:0

v
Scan QR Code
&et=6FD39CDBE3BBFA782FA6D2489687B7BDCB7F519EB41453A646E33D2CA1F3FFFBAAE3273843758E016BDD249D68DE8EB7FE21FA62950836E817FED23588D55D959D2EC1C5FD31C240&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=67289AFF6305E306&aid=5BE9812A2866FE174153827D862CE533&vid=&iid=38B194292C032A66&sid=89AC6B0ADBEA2741&eid=4D7D059FFBF006B9&fileno=20080316&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="67289AFF6305E306"; var my_aid="5BE9812A2866FE174153827D862CE533";